These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 32808491)
1. Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands. Burg L; Timmermans M; van der Aa M; Boll D; Rovers K; de Hingh I; van Altena A J Gynecol Oncol; 2020 Sep; 31(5):e58. PubMed ID: 32808491 [TBL] [Abstract][Full Text] [Related]
2. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study. van Niekerk CC; van Dijck JAAM; Verbeek ALM Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847 [TBL] [Abstract][Full Text] [Related]
3. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. Zuna RE; Behrens A J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429 [TBL] [Abstract][Full Text] [Related]
4. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin. Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935 [TBL] [Abstract][Full Text] [Related]
5. [Histopathological characteristics of genital and breast cancer included in epidemiologic study cohort]. Matei M; Azoicăi D Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):540-8. PubMed ID: 21495363 [TBL] [Abstract][Full Text] [Related]
6. Risk of endometrial, ovarian, vulvar, and vaginal cancers after a positive cervical cytology followed by negative histology. Viikki M; Pukkala E; Hakama M Obstet Gynecol; 1998 Aug; 92(2):269-73. PubMed ID: 9699765 [TBL] [Abstract][Full Text] [Related]
7. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Kosary CL Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784 [TBL] [Abstract][Full Text] [Related]
8. Histo-epidemiological aspects of gynecological and breast cancers at the University Teaching Hospital of Yaoundé. Kemo ADD; Nkegoum B; Nangue C; Djuikwo F; Bita'a LB; Tebeu PM Pan Afr Med J; 2019; 33():130. PubMed ID: 31558929 [TBL] [Abstract][Full Text] [Related]
9. Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study. Lurvink RJ; Rijken A; Bakkers C; Aarts MJ; Kunst PWA; van de Borne BE; van Erning FN; de Hingh IHJT Clin Exp Metastasis; 2021 Jun; 38(3):295-303. PubMed ID: 33738641 [TBL] [Abstract][Full Text] [Related]
10. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival. Williams MG; Bandera EV; Demissie K; Rodríguez-Rodríguez L Obstet Gynecol; 2009 Apr; 113(4):783-789. PubMed ID: 19305320 [TBL] [Abstract][Full Text] [Related]
11. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon. Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061 [TBL] [Abstract][Full Text] [Related]
12. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region]. Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416 [TBL] [Abstract][Full Text] [Related]
13. Telomerase activity in gynecological tumors. Sakamoto M; Toyoizumi T; Kikuchi Y; Okamoto A; Nakayama H; Aoki D; Yamamoto K; Hata H; Sugishita T; Tenjin Y Oncol Rep; 2000; 7(5):1003-9. PubMed ID: 10948330 [TBL] [Abstract][Full Text] [Related]
14. Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013. Michaan N; Gortzak-Uzan L; Grisario D; Laskov I Int J Gynaecol Obstet; 2018 Aug; 142(2):176-181. PubMed ID: 29742279 [TBL] [Abstract][Full Text] [Related]
15. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis. Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963 [TBL] [Abstract][Full Text] [Related]
16. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma? Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124 [TBL] [Abstract][Full Text] [Related]
17. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686 [TBL] [Abstract][Full Text] [Related]
18. Risk of Gynecologic Cancer According to the Type of Endometriosis. Saavalainen L; Lassus H; But A; Tiitinen A; Härkki P; Gissler M; Pukkala E; Heikinheimo O Obstet Gynecol; 2018 Jun; 131(6):1095-1102. PubMed ID: 29742675 [TBL] [Abstract][Full Text] [Related]
19. [Metastatic mechanisms of uterine malignancies and therapeutic consequences]. Lax SF; Tamussino KF; Lang PF Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531 [TBL] [Abstract][Full Text] [Related]